Juvenile idiopathic arthritis (JIA) is the most common chronic rheumatic disease in the
paediatric population. JIA comprises a heterogeneous group of disorders with different onset …

Immune checkpoint inhibitors are associated with immune-related adverse events (irAEs),
including arthritis (arthritis-irAE). Management of arthritis-irAE is challenging because …

Non-infectious uveitis (NIU) is a potentially sight-threatening disease. Effector CD4+ T cells,
especially interferon-γ-(IFNγ) producing Th1 cells and interleukin-17-(IL-17) producing Th17 …

Oligoarticular juvenile idiopathic arthritis (oligo JIA) is the most common form of chronic
inflammatory arthritis in children, yet the cause of this disease remains unknown. To …

Th17 cells are important players in host defense against pathogens such as Staphylococcus
aureus, Candida albicans, and Bacillus anthracis. Th17 cell-mediated inflammation, under …

Monocytes (Mos) and macrophages (Mφs) are key players in the innate immune system and
are critical in coordinating the initiation, expansion, and regression of many autoimmune …

Objective Tregs are crucial for immune regulation, and environment‐driven adaptation of
effector (e) Tregs is essential for local functioning. However, the extent of human Treg …

Objective To evaluate efficacy and safety of total glucosides of paeony in the treatment of 5
types of inflammatory arthritis Methods Databases such as Pubmed, Cochran Library …

Introduction The management of a child with juvenile idiopathic arthritis (JIA) requires a
combination of pharmacological, physical, and psychosocial therapies in order to induce …

Juvenile idiopathic arthritis (JIA) is the most common chronic rheumatic condition in
childhood. The disease etiology remains largely unknown; however, a key role in JIA …